IMMUNOGENICITY

Clinical trials for IMMUNOGENICITY explained in plain language.

Never miss a new study

Get alerted when new IMMUNOGENICITY trials appear

Sign up with your email to follow new studies for IMMUNOGENICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

Groundbreaking trial aims to protect moms and babies from mpox

Prevention Ongoing

This study is testing the safety and immune response of the MVA-BN mpox vaccine in pregnant and recently delivered women in the Democratic Republic of the Congo, where mpox is a risk. It will enroll 359 women to receive two vaccine doses either during pregnancy or right after giv…

Matched conditions: IMMUNOGENICITY

Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: Prevention

Last updated Mar 30, 2026 14:28 UTC

IMMUNOGENICITY

Get alerted when new IMMUNOGENICITY trials appear

Groundbreaking trial aims to protect moms and babies from mpox